BNP Paribas Financial Markets
VIVE

BNP Paribas Financial Markets’s VIVEVE MED INC VIVE Stock Holding History

BNP Paribas Financial Markets’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2
Closed -$764 – 4566
2019
Q2 		$764 Hold
2
– – ﹤0.01% 4381
2019
Q1 		$1.84K Hold
2
– – ﹤0.01% 4121
2018
Q4 		$2.06K Hold
2
– – ﹤0.01% 3793
2018
Q3 		$5.26K Hold
2
– – ﹤0.01% 4032
2018
Q2 		$5.34K Sell
2
-4
-67% -$11.5K ﹤0.01% 4073
2018
Q1 		$21.2K Buy
6
+3
+100% +$13K ﹤0.01% 3912
2017
Q4 		$15.5K Buy
3
+2
+200% +$10.4K ﹤0.01% 3989
2017
Q3 		$7.66K Sell
1
-1
-50% -$6.17K ﹤0.01% 3935
2017
Q2 		$11.3K Buy
+2
New +$14.9K ﹤0.01% 3914

Other funds holding VIVE

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets's VIVE Position: Q3 2019 in Review

BNP Paribas Financial Markets sold out of VIVEVE MED INC (VIVE) in Q3 2019, closing a stake of 2 shares — an estimated $764 sold.

BNP Paribas Financial Markets first reported a position in VIVE in Q2 2017 and held it in 9 quarters. The position peaked at $21.2K in Q1 2018. 11 funds tracked by Wall St. Rank hold VIVE as of Q3 2019.

  • BNP Paribas Financial Markets reported no remaining VIVEVE MED INC position as of Q3 2019 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 VIVEVE MED INC shares in Q3 2019, an estimated $764.
  • BNP Paribas Financial Markets first reported a position in VIVEVE MED INC in Q2 2017 and held it in 9 quarters.
  • BNP Paribas Financial Markets's VIVEVE MED INC position peaked at $21.2K in Q1 2018.
  • 11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.